Click here to RETURN to the previous page

Factor Nine: Liverzyne

Detoxification & Support Formulation

It is not "fate" that decides who gets sick and who doesn't! In today's unhealthy environment where, according to the EPA, even drinking water contains over 700 chemicals including lead, our exposure to harmful substances has escalated to incalculable levels. Our "liver filter," the sinusoidal system, is easily overloaded under such conditions.

Modern medicine and unhealthy diet programs promulgated by members of the medical profession exacerbate the situation. Consider the following:

Over the counter Painkillers are the Leading Cause of Liver Failure!

Acetaminophen products, like Tylenol, are responsible for tens of thousands of liver poisonings a year, with hundreds of fatalities. A recent three-year study published in the Annals of Internal Medicine looked at 308 patients with acute liver failure from 17 different liver care centers and determined that acetaminophen accounted for 39% of cases.

Swiss researchers report that NSAID (Non Steroidal Anti-Inflammatory Drugs) pain medications are probably killing 2,000 patients each year in the UK (Great Britain) and suggest that one in 1,000 patients who take these drugs for at least two years will die from them.

High Protein Diets can lead to Mental Confusion.

Too much daily protein may cause hepatic encephalopathy (mental confusion) according to the Hepatitis Foundation. This occurs when the amount of dietary protein is greater than the liver's ability to use it. This results in a build-up of toxins that can interfere with brain function. Diet plans, such as the Atkins Diet, can cause weight loss in individuals, however, the down side the individual pays for this weight reduction is never stated!

Thanks to modern OTC pain relievers and governmental failure to regulate today's industrial and agri-business practices which poison our soil, air, and water, twenty-five million (25,000,000) Americans are or have been affected with liver disease.

Nearly 20 years ago, the Environmental Protection Agency (EPA) estimated that up to 20% of all deaths in America were due to pollutants and environmental hazards. Since then, environmental conditions have deteriorated!

A simple 1~ 2 ~3  protocol is necessary to achieve maximum liver detoxification & support:

1.  Proper assimilation of food and gastrointestinal support. Liver dysfunction begins with digestive problems caused by enzyme depletion. The pancreas is the major producer of digestive enzymes and is the first organ to be overwhelmed by toxins. Fats are the most difficult foods to be broken down by pancreatic enzymes which is why "fatty liver" affects more than 50% of people over the age of 50!

Factor Seven: Digestin or Ultra Veggie Enzymes (vegetarian formulation) complements the body's enzyme production and ameliorates stress to the pancreas and liver. Enzyme supplementation is therefore recommended as an important adjunct to liver detoxification.

2.  There are two major detoxification pathways inside the liver, Phase I & Phase II.

Phase I detox pathway is known as the Cyto-chrome P-450 monooxygenase system and is the body's way of transforming non-polar, non-water soluble toxins into less harmful compounds in preparation for Phase II. During this process free radicals are produced which can damage the liver cells. Antioxidants, such as vitamins C and E, natural carotenoids, and the B complex group, reduce such damage. If sufficient antioxidants are lacking, the liver becomes stressed and Phase I detox is jeopardized.

Factor One: Bio-Immunizer is a powerful antioxidant which compliments the antioxidant compounds found in Factor Nine: Liverzyne for those patients who show symptoms of liver stress or who work in high risk environments.

Phase II detox is known as the conjugation pathway in which water soluble chemicals are ready to be turned into excretable substances. It is here that the selected herbs and natural sulphur compounds and enzymes formulated in Factor Nine: Liverzyne facilitate the Phase II detox process.

3.  The liver takes fat in the form of cholesterol and pumps it via the bile into the intestines where it will be eliminated provided the diet has sufficient fiber - an intake of 40 to 50 grams per day. (Most American diets are 20 grams per day!)

Patients suffering from liver dysfunction usually have difficulty metabolizing fats and have high cholesterol levels. If bodily waste cannot be efficiently eliminated, an accumulation of toxins will build up in the lymph, blood stream, and intestines. It is therefore important that a fiber based supplement such as Factor Eight: Natura Cleanse, be incorporated into the liver detox protocol if the patient's diet is high in fat and fried foods and/or low in vegetables and fruits.

Factor Eight: Natura Cleanse is a fiber-based detoxification and intestinal rejuvenator containing Plantain mucilage, one of the best cholesterol lowering fibers available, and Fenugreek seed, proven to stimulate liver function and pancreatic secretion.

We caution against fasting for any patient diagnosed with "fatty or sluggish liver." Fasting is an extreme and temporary method of cleansing the body and can cause acute side effects. The liver, like any filter, needs to be cleansed regularly and it is easier to do so on a daily basis. This is easily and pleasantly achieved by adhering to the simple three-step protocol above.


    • Hirsch, GP, Good Health with dl-Methionine, Preventhium International, Sugar Hill, Ga. 2000Quillin, P, Healing Nutrients, p. 161, 1987
    • Abrams, K, Algae to the Rescue, Logan House, p. 26, 1996
    • Borish, L, Immunological Investigations, vol 16, pp. 501-532, 1987
    • National Center for Health Statistics, United States, 1991, (CDHHS Pub #92-1232
    • Evans, MD, et al, Chem. Biol. Interactions, vol 79, pp. 151-164, 1991
    • Bartus, R, el al, Science, vol 209, p. 301, 1980
    • Zeisel, SH, Journal Am. Coll. Nutrition, 11:5, pp. 473-481, Oct 1992
    • Kuksis, A, et al, Present Knowledge in Nutrition, Chapter 27, The Nutrition Foundation, Washington, DC, 1984
    • Kirchhoff, R, et al, Phytomedicine, vol 1, pp. 107-115, 1994
    • Kraft, K, Phytomedicine, 4(4), pp. 369-378, 1997
    • Blumenthal, M, ed. The Complete German Commission E Monographs, Intergrative Medicine Communications, p. 84, 1998
    • Englisch, W, et al, Arzneimittelforschung, vol 50, pp. 260-65, 2000
    • Brand, N, Z. Phytother., vol II, pp. 169-175, 1990
    • Grunwald, J, et al, PDR for Herbal Medicines, 2nd Ed., Medical Economics co., Montvale, NJ, pp. 246-46, 2000
    • Swanston-Flatt, SK, et al, Diabetes Res., vol 10(2), pp. 69-73, 1989
    • Newell, C, et al, Journal of Herbal Medicines: A Guide for Healthcare Professionals, Pharmaceutical Press, London, England, 1996
    • Boone, K, Clinical Applications of Chinese Herbs, Phytotherapy Press, Queensland, Australia, 1997
    • Ohtaki, Y, et al, Biochem Pharmacol, vol 46, pp. 1081-1085, 1993
    • Fujihashi, T, et al, Antimicrob Agents Chemother., vol 39, pp.2000-2007, 1995
    • Hikino, H, et al, Planta Medica, vol 50, pp. 248-250, 1984
    • Wagner, H, Natural Products as Medicinal Agents, Hippokrates-Verlag, Stuttgart, Germany, 1981
    • Desplaces, A, et al, Arzneimittel-Forsch, vol 25, pp. 89-96, 1975
    • Valenzuela, A, et al, Biochem Pharm, vol 34, pp. 2209-2212, 1985
    • Sarre, H, Experience in the treatment of chronic hepatopathies with silymarin, Arzneimittel-Forsch, vol 21, pp. 1209-1212, 1971
    • Sonnenbichler, J, et al, Plant Flavonoids in Biology and Medicine, Alan R. Liss, NY, pp. 319-331, 1986
    • Sonnenbichler, J, et al, Biochem Pharm, vol 35, pp. 538-541, 1986
    • Shimizu, K, et al, Journal of Pharmaco. Dyn, vol 7, pp. 891-899, 1984
    • Yamamoto, M, et al, Arzniem-Forsh, vol 25, pp. 1021-1040, 1975
    • Ahn, B, et al, Planta Med, 64(3), pp. 220-224, Apr 1998
    • Lee, WM, Annals of Internal Medicine, pp. 947-954, Dec 17, 2002
    • Tramer, M, et al, University Hospital, Geneva, Pain, March 2000
    • American Liver Association website
    • Pollitt, E, et al, American Journal of Clinical Nutrition, vol 42, p. 348, Aug 1985